Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02616601 · ClinicalTrials.gov registry record · Phase 3
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
A Phase 3 study, sponsored by Actavis.
- Completed
- Registry status
- Phase 3
- Development phase
- 422
- Enrollment target
NCT02616601 is a Phase 3 study that has completed, run by Actavis. The registered enrollment target is 422 participants.
The verdict
NCT02616601, a Phase 3 study, has completed, sponsored by Actavis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 422 participants
- Enrollment target
Study Summary
This study is to evaluate the efficacy and safety of a generic formulation of fluorouracil 0.5% cream against the brand product (Carac) in participants with actinic keratoses.
Interventions
- DRUG Vehicle Cream
- DRUG Generic Fluorouracil Cream
- DRUG Carac® (Fluorouracil) Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 422 participants |
| Start Date | 2015-02-27 |
| Est. Completion | 2015-09-17 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02616601
The ClinicalTrials.gov registry entry for NCT02616601 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 422 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Actavis, which has 79 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Vehicle Cream is the first listed.
NCT02616601 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02616601 about?
NCT02616601 is a clinical study titled "Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis". This study is to evaluate the efficacy and safety of a generic formulation of fluorouracil 0.5% cream against the brand product (Carac) in participants with actinic keratoses.
What is the current status of trial NCT02616601?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 422 participants. The study started on 2015-02-27. Estimated completion is 2015-09-17.
What interventions are being tested in trial NCT02616601?
The interventions under investigation include: Vehicle Cream (DRUG), Generic Fluorouracil Cream (DRUG), Carac® (Fluorouracil) Cream (DRUG).
Who is sponsoring clinical trial NCT02616601?
This trial is sponsored by Actavis, which has 79 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.